ImClone Systems (IMCL, $64.59, down $0.75) has responded to Bristol-Myers Squibb (BMY, $21.49, up $0.38) offer for a buyout of $4.9 billion and has said the bid is too low. The company said it is evaluating the deal, but has stated that it already feels it’s too low. The storyRead more

More